Artivion announces closing of transactions to exchange $99.5 million in principal amount of its 4.250% convertible notes due 2025 for common stock

Atlanta , may 28, 2025 /prnewswire/ -- artivion, inc. (nyse: aort), a leading cardiac and vascular surgery company focused on aortic disease, today announced the closing of transactions related to previously announced, privately negotiated exchange agreements with certain holders (the "holders") of its 4.250% convertible senior notes due 2025 (the "notes"). the closing transactions included the closing of an additional, privately negotiated agreement with a separate holder.
AORT Ratings Summary
AORT Quant Ranking